BofA Global Research cuts Revolution Medicines price objective to $264 from $265
RVMD•BofA Global Research cut its price objective for Revolution Medicines to $264 from $265.
Related News
Tractor Supply Company: BofA Global Research raises price objective to $34 from $32
TSCO•
Nasdaq trade halt continues; reason not available at 10:10 a.m.
UCFI•
Definium rises as J.P. Morgan starts coverage with overweight rating on LSD-based therapy
DFTX•
Merck & Co Inc: BofA Global Research cuts price objective to $163 from $166
MRK•
Global markets: Oil eases, bringing some respite to stocks and battered bonds
SPY•